Get started
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

No trades
See on Supercharts
Overview Financials News Ideas Discussions Technicals Forecast Seasonals
Bonds

4AB bonds

Below is the list of ABBVIE INC corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol
YTM %
Volume
Price %
Coupon %
Maturity date
Outstanding amt
Face value
Min denom amt
Issuer
AA5QDALLERGAN FNDG 15/25
8.79%099.85%3.80%2025-03-15130.22 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
8.14%50 K74.10%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7.69%15 K77.85%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7.13%4 K80.46%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6.31%750 K89.19%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.76%10.98 M84.56%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.74%26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.65%088.41%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.57%1.5 M89.59%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.56%091.80%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.55%1.92 M93.11%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.54%150 K92.53%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.47%8 M92.40%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.47%5.17 M94.17%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.46%21.45 M100.46%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.45%3.04 M88.59%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.39%42.91 M100.13%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
5.33%4.57 M99.95%3.80%2025-03-152.89 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5.33%34.49 M103.16%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.25%1.46 M100.91%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.12%094.15%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.02%096.51%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
5.00%099.73%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.97%1.16 M97.22%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.89%14.21 M101.03%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4.89%42.53 M102.12%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.67%30.01 M94.32%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.59%2.58 M101.72%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4.57%8.01 M101.24%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.46%5.32 M101.17%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.39%098.65%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
4.38%27.09 M100.71%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.36%4.2 M99.64%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.32%2.76 M97.81%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.30%12.36 M100.94%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3.86%096.53%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3.80%096.18%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3.79%093.91%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
4ABGABBVIE 19/31
3.03%090.08%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3.01%0102.15%3.80%2025-03-151.27 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2.90%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2.88%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.83%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591491ABBVIE 20/29
2.78%097.51%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2.71%098.02%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.71%099.72%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.59%095.33%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.35%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.